Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 169

1.

Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.

Wormsbecker AE, Wong K, Jamieson FB, Crowcroft NS, Deeks SL.

Vaccine. 2015 Aug 20. pii: S0264-410X(15)01145-7. doi: 10.1016/j.vaccine.2015.08.023. [Epub ahead of print]

2.

Multi-Province Listeriosis Outbreak Linked to Contaminated Deli Meat Consumed Primarily in Institutional Settings, Canada, 2008.

Currie A, Farber JM, Nadon C, Sharma D, Whitfield Y, Gaulin C, Galanis E, Bekal S, Flint J, Tschetter L, Pagotto F, Lee B, Jamieson F, Badiani T, MacDonald D, Ellis A, May-Hadford J, McCormick R, Savelli C, Middleton D, Allen V, Tremblay FW, MacDougall L, Hoang L, Shyng S, Everett D, Chui L, Louie M, Bangura H, Levett PN, Wilkinson K, Wylie J, Reid J, Major B, Engel D, Douey D, Huszczynski G, Di Lecci J, Strazds J, Rousseau J, Ma K, Isaac L, Sierpinska U.

Foodborne Pathog Dis. 2015 Aug;12(8):645-52. doi: 10.1089/fpd.2015.1939. Epub 2015 Jun 3.

PMID:
26258258
3.

Increased risk of mycobacterial infections associated with anti-rheumatic medications.

Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-Austin A, Bombardier C, Marras TK.

Thorax. 2015 Jul;70(7):677-82. doi: 10.1136/thoraxjnl-2014-206470. Epub 2015 Apr 24.

PMID:
25911222
4.

Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013.

Tsang RS, Hoang L, Tyrrell G, Horsman G, Wylie J, Jamieson FB, Lefebvre B, Taha MK.

J Med Microbiol. 2015 Feb;64(Pt 2):174-9. doi: 10.1099/jmm.0.000006-0.

PMID:
25627205
5.
6.

Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post MenC-conjugate vaccine era, 2009-2013.

Tsang RS, Hoang L, Tyrrell G, Horsman G, Wylie J, Jamieson FB, Lefebvre B, Taha MK.

J Med Microbiol. 2015 Jan 13. pii: jmm.0.000006. doi: 10.1099/jmm.0.000006. [Epub ahead of print]

PMID:
25587078
7.

Multidrug-resistant tuberculosis: Treatment and outcomes of 93 patients.

Brode SK, Varadi R, McNamee J, Malek N, Stewart S, Jamieson FB, Avendano M.

Can Respir J. 2015 Mar-Apr;22(2):97-102. Epub 2014 Dec 10.

8.

Variable agreement among experts regarding Mycobacterium avium complex lung disease.

Marras TK, Prevots DR, Jamieson FB, Winthrop KL; Pulmonary MAC Outcomes Group.

Respirology. 2015 Feb;20(2):348-51. doi: 10.1111/resp.12440. Epub 2014 Nov 28.

9.

Marked microevolution of a unique Mycobacterium tuberculosis strain in 17 years of ongoing transmission in a high risk population.

Mehaffy C, Guthrie JL, Alexander DC, Stuart R, Rea E, Jamieson FB.

PLoS One. 2014 Nov 18;9(11):e112928. doi: 10.1371/journal.pone.0112928. eCollection 2014.

10.

Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years.

Tsang RS, Shuel M, Jamieson FB, Drews S, Hoang L, Horsman G, Lefebvre B, Desai S, St-Laurent M.

Int J Infect Dis. 2014 Nov;28:65-9. doi: 10.1016/j.ijid.2014.08.002. Epub 2014 Sep 22.

11.

Multilocus sequence typing of Mycobacterium xenopi.

Alexander DC, Marras TK, Ma JH, Mirza S, Liu D, Kus JV, Soualhine H, Escuyer V, Warshauer D, Brode SK, Farrell DJ, Jamieson FB.

J Clin Microbiol. 2014 Nov;52(11):3973-7. doi: 10.1128/JCM.01601-14. Epub 2014 Sep 10.

12.

Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada.

Tu HA, Deeks SL, Morris SK, Strifler L, Crowcroft N, Jamieson FB, Kwong JC, Coyte PC, Krahn M, Sander B.

Vaccine. 2014 Sep 22;32(42):5436-46. doi: 10.1016/j.vaccine.2014.07.096. Epub 2014 Aug 12.

PMID:
25131732
13.

Utility of gastric aspirates for diagnosing tuberculosis in children in a low prevalence area: predictors of positive cultures and significance of non-tuberculous mycobacteria.

Kordy F, Richardson SE, Stephens D, Lam R, Jamieson F, Kitai I.

Pediatr Infect Dis J. 2015 Jan;34(1):91-3. doi: 10.1097/INF.0000000000000498.

PMID:
25101762
14.
15.

Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.

Marchand-Austin A, Rawte P, Toye B, Jamieson FB, Farrell DJ, Patel SN.

Anaerobe. 2014 Aug;28:120-5. doi: 10.1016/j.anaerobe.2014.05.015. Epub 2014 Jun 9.

PMID:
24923267
16.

Interferon-gamma release assays piloted as a latent tuberculous infection screening tool in Canadian federal inmates.

Schwartz IS, Bach PJ, Roscoe B, Majury A, Hopman WM, Ellis E, Garrahan T, Smith J, Barkley R, Panaro L, Jamieson F, Froats C, Gemmill I, Wobeser WL.

Int J Tuberc Lung Dis. 2014 Jul;18(7):787-92. doi: 10.5588/ijtld.13.0816.

PMID:
24902553
17.

Surveillance of antimicrobial resistance in contemporary clinical isolates of Bordetella pertussis in Ontario, Canada.

Marchand-Austin A, Memari N, Patel SN, Tang P, Deeks SL, Jamieson FB, Crowcroft NS, Farrell DJ.

Int J Antimicrob Agents. 2014 Jul;44(1):82-4. doi: 10.1016/j.ijantimicag.2014.04.001. Epub 2014 May 2. No abstract available.

PMID:
24837412
18.

Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis.

Jamieson FB, Guthrie JL, Neemuchwala A, Lastovetska O, Melano RG, Mehaffy C.

J Clin Microbiol. 2014 Jun;52(6):2157-62. doi: 10.1128/JCM.00691-14. Epub 2014 Apr 16.

19.

Genomic analysis of Pseudomonas aeruginosa PA96, the host of carbapenem resistance plasmid pOZ176.

Déraspe M, Alexander DC, Xiong J, Ma JH, Low DE, Jamieson FB, Roy PH.

FEMS Microbiol Lett. 2014 Jul;356(2):212-6. doi: 10.1111/1574-6968.12435. Epub 2014 Apr 16.

20.

Letter to the editor.

Tsang RS, Jamieson FB, Lefebvre B, Gilca R.

Can J Infect Dis Med Microbiol. 2014 Spring;25(1):8-38. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk